{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:11:34Z","timestamp":1790035894916,"version":"4.0.1"},"reference-count":199,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1038\/s41574-024-01052-1","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T07:18:16Z","timestamp":1731482296000},"page":"180-195","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Growth hormone-releasing hormone and its analogues in health and disease"],"prefix":"10.1038","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4164-7313","authenticated-orcid":false,"given":"Riccarda","family":"Granata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iacopo","family":"Gesmundo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9635-4860","authenticated-orcid":false,"given":"Charlotte","family":"Steenblock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzhi","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4740-2325","authenticated-orcid":false,"given":"Wei","family":"Sha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezio","family":"Ghigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7751-5032","authenticated-orcid":false,"given":"Joshua M.","family":"Hare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5211-2536","authenticated-orcid":false,"given":"Stefan R.","family":"Bornstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew V.","family":"Schally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,13]]},"reference":[{"key":"1052_CR1","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1210\/en.2019-00111","volume":"160","author":"AV Schally","year":"2019","unstructured":"Schally, A. V. et al. Actions and potential therapeutic applications of growth hormone-releasing hormone agonists. Endocrinology 160, 1600\u20131612 (2019).","journal-title":"Endocrinology"},{"key":"1052_CR2","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s40618-016-0440-x","volume":"39","author":"R Granata","year":"2016","unstructured":"Granata, R. Peripheral activities of growth hormone-releasing hormone. J. Endocrinol. Invest. 39, 721\u2013727 (2016).","journal-title":"J. Endocrinol. Invest."},{"key":"1052_CR3","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3181\/00379727-119-30138","volume":"119","author":"AV Schally","year":"1965","unstructured":"Schally, A. V., Steelman, S. L. & Bowers, C. Y. Effect of hypothalamic extracts on release of growth hormone in vitro. Proc. Soc. Exp. Biol. Med. 119, 208\u2013212 (1965).","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"1052_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1210\/endo-69-2-225","volume":"69","author":"S Reichlin","year":"1961","unstructured":"Reichlin, S. Growth hormone content of pituitaries from rats with hypothalamic lesions. Endocrinology 69, 225\u2013230 (1961).","journal-title":"Endocrinology"},{"key":"1052_CR5","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3181\/00379727-122-31260","volume":"122","author":"AV Schally","year":"1966","unstructured":"Schally, A. V. et al. Purification of growth hormone-releasing factor from beef hypothalamus. Proc. Soc. Exp. Biol. Med. 122, 821\u2013823 (1966).","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"1052_CR6","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1210\/endo-84-6-1493","volume":"84","author":"AV Schally","year":"1969","unstructured":"Schally, A. V. et al. Isolation of growth hormone-releasing hormone (GRH) from porcine hypothalami. Endocrinology 84, 1493\u20131506 (1969).","journal-title":"Endocrinology"},{"key":"1052_CR7","first-page":"259","volume":"74","author":"LA Frohman","year":"1981","unstructured":"Frohman, L. A. & Szabo, M. Ectopic production of growth hormone-releasing factor by carcinoid and pancreatic islet tumors associated with acromegaly. Prog. Clin. Biol. Res. 74, 259\u2013271 (1981).","journal-title":"Prog. Clin. Biol. Res."},{"key":"1052_CR8","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/300276a0","volume":"300","author":"J Rivier","year":"1982","unstructured":"Rivier, J., Spiess, J., Thorner, M. & Vale, W. Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour. Nature 300, 276\u2013278 (1982).","journal-title":"Nature"},{"key":"1052_CR9","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1126\/science.6812220","volume":"218","author":"R Guillemin","year":"1982","unstructured":"Guillemin, R. et al. Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science 218, 585\u2013587 (1982).","journal-title":"Science"},{"key":"1052_CR10","doi-asserted-by":"publisher","first-page":"4302","DOI":"10.1073\/pnas.81.14.4302","volume":"81","author":"N Ling","year":"1984","unstructured":"Ling, N. et al. Isolation, primary structure, and synthesis of human hypothalamic somatocrinin: growth hormone-releasing factor. Proc. Natl Acad. Sci. USA 81, 4302\u20134306 (1984).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR11","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.tem.2011.03.006","volume":"22","author":"H Kiaris","year":"2011","unstructured":"Kiaris, H., Chatzistamou, I., Papavassiliou, A. G. & Schally, A. V. Growth hormone-releasing hormone: not only a neurohormone. Trends Endocrinol. Metab. 22, 311\u2013317 (2011).","journal-title":"Trends Endocrinol. Metab."},{"key":"1052_CR12","first-page":"1734","volume":"6","author":"KE Mayo","year":"1992","unstructured":"Mayo, K. E. Molecular cloning and expression of a pituitary-specific receptor for growth hormone-releasing hormone. Mol. Endocrinol. 6, 1734\u20131744 (1992).","journal-title":"Mol. Endocrinol."},{"key":"1052_CR13","first-page":"77","volume":"7","author":"BD Gaylinn","year":"1993","unstructured":"Gaylinn, B. D. et al. Molecular cloning and expression of a human anterior pituitary receptor for growth hormone-releasing hormone. Mol. Endocrinol. 7, 77\u201384 (1993).","journal-title":"Mol. Endocrinol."},{"key":"1052_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18945-0","volume":"11","author":"F Zhou","year":"2020","unstructured":"Zhou, F. et al. Structural basis for activation of the growth hormone-releasing hormone receptor. Nat. Commun. 11, 5205 (2020).","journal-title":"Nat. Commun."},{"key":"1052_CR15","doi-asserted-by":"publisher","first-page":"10561","DOI":"10.1073\/pnas.180313297","volume":"97","author":"Z Rekasi","year":"2000","unstructured":"Rekasi, Z., Czompoly, T., Schally, A. V. & Halmos, G. Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers. Proc. Natl Acad. Sci. USA 97, 10561\u201310566 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR16","doi-asserted-by":"publisher","first-page":"17424","DOI":"10.1073\/pnas.0506844102","volume":"102","author":"A Havt","year":"2005","unstructured":"Havt, A. et al. The expression of the pituitary growth hormone-releasing hormone receptor and its splice variants in normal and neoplastic human tissues. Proc. Natl Acad. Sci. USA 102, 17424\u201317429 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR17","doi-asserted-by":"publisher","first-page":"9512","DOI":"10.1073\/pnas.1533185100","volume":"100","author":"H Kiaris","year":"2003","unstructured":"Kiaris, H. et al. Ligand-dependent and -independent effects of splice variant 1 of growth hormone-releasing hormone receptor. Proc. Natl Acad. Sci. USA 100, 9512\u20139517 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR18","doi-asserted-by":"publisher","first-page":"5575","DOI":"10.1073\/pnas.0700407104","volume":"104","author":"N Barabutis","year":"2007","unstructured":"Barabutis, N. et al. Stimulation of proliferation of MCF-7 breast cancer cells by a transfected splice variant of growth hormone-releasing hormone receptor. Proc. Natl Acad. Sci. USA 104, 5575\u20135579 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S1043-2760(02)00613-6","volume":"13","author":"LA Frohman","year":"2002","unstructured":"Frohman, L. A. & Kineman, R. D. Growth hormone-releasing hormone and pituitary development, hyperplasia and tumorigenesis. Trends Endocrinol. Metab. 13, 299\u2013303 (2002).","journal-title":"Trends Endocrinol. Metab."},{"key":"1052_CR20","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nrendo.2018.22","volume":"14","author":"MB Ranke","year":"2018","unstructured":"Ranke, M. B. & Wit, J. M. Growth hormone \u2013 past, present and future. Nat. Rev. Endocrinol. 14, 285\u2013300 (2018).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1052_CR21","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.4161\/cc.9.20.13787","volume":"9","author":"N Barabutis","year":"2010","unstructured":"Barabutis, N. & Schally, A. V. Growth hormone-releasing hormone: extrapituitary effects in physiology and pathology. Cell Cycle 9, 4110\u20134116 (2010).","journal-title":"Cell Cycle"},{"key":"1052_CR22","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.peptides.2013.12.010","volume":"52","author":"R Cai","year":"2014","unstructured":"Cai, R. et al. Synthesis of new potent agonistic analogs of growth hormone-releasing hormone (GHRH) and evaluation of their endocrine and cardiac activities. Peptides 52, 104\u2013112 (2014).","journal-title":"Peptides"},{"key":"1052_CR23","doi-asserted-by":"publisher","first-page":"1231363","DOI":"10.3389\/fimmu.2023.1231363","volume":"14","author":"G Granato","year":"2023","unstructured":"Granato, G. et al. Growth hormone-releasing hormone antagonist MIA-602 inhibits inflammation induced by SARS-CoV-2 spike protein and bacterial lipopolysaccharide synergism in macrophages and human peripheral blood mononuclear cells. Front. Immunol. 14, 1231363 (2023).","journal-title":"Front. Immunol."},{"key":"1052_CR24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2216814120","volume":"120","author":"M Boido","year":"2023","unstructured":"Boido, M. et al. Agonist of growth hormone-releasing hormone improves the disease features of spinal muscular atrophy mice. Proc. Natl Acad. Sci. USA 120, e2216814120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2109600118","volume":"118","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. Agonistic analog of growth hormone-releasing hormone promotes neurofunctional recovery and neural regeneration in ischemic stroke. Proc. Natl Acad. Sci. USA 118, e2109600118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/ncpendmet0677","volume":"4","author":"AV Schally","year":"2008","unstructured":"Schally, A. V., Varga, J. L. & Engel, J. B. Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer. Nat. Clin. Pract. Endocrinol. Metab. 4, 33\u201343 (2008).","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"key":"1052_CR27","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S1043-2760(99)00209-X","volume":"10","author":"AV Schally","year":"1999","unstructured":"Schally, A. V. & Varga, J. L. Antagonistic analogs of growth hormone-releasing hormone: new potential antitumor agents. Trends Endocrinol. Metab. 10, 383\u2013391 (1999).","journal-title":"Trends Endocrinol. Metab."},{"key":"1052_CR28","doi-asserted-by":"publisher","first-page":"bqac209","DOI":"10.1210\/endocr\/bqac209","volume":"164","author":"N Barabutis","year":"2022","unstructured":"Barabutis, N., Akhter, M. S., Kubra, K. T. & Jackson, K. Growth hormone-releasing hormone in endothelial inflammation. Endocrinology 164, bqac209 (2022).","journal-title":"Endocrinology"},{"key":"1052_CR29","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.peptides.2017.01.009","volume":"89","author":"M Zarandi","year":"2017","unstructured":"Zarandi, M. et al. Synthesis and structure-activity studies on novel analogs of human growth hormone releasing hormone (GHRH) with enhanced inhibitory activities on tumor growth. Peptides 89, 60\u201370 (2017).","journal-title":"Peptides"},{"key":"1052_CR30","doi-asserted-by":"publisher","first-page":"12028","DOI":"10.1073\/pnas.1813375115","volume":"115","author":"AV Schally","year":"2018","unstructured":"Schally, A. V. et al. Agonists of growth hormone-releasing hormone (GHRH) inhibit human experimental cancers in vivo by down-regulating receptors for GHRH. Proc. Natl Acad. Sci. USA 115, 12028\u201312033 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR31","doi-asserted-by":"publisher","first-page":"4872","DOI":"10.1073\/pnas.92.11.4872","volume":"92","author":"J Izdebski","year":"1995","unstructured":"Izdebski, J. et al. Synthesis and biological evaluation of superactive agonists of growth hormone-releasing hormone. Proc. Natl Acad. Sci. USA 92, 4872\u20134876 (1995).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR32","doi-asserted-by":"publisher","first-page":"12623","DOI":"10.1073\/pnas.1005098107","volume":"107","author":"B Ludwig","year":"2010","unstructured":"Ludwig, B. et al. Agonist of growth hormone-releasing hormone as a potential effector for survival and proliferation of pancreatic islets. Proc. Natl Acad. Sci. USA 107, 12623\u201312628 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR33","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1073\/pnas.0914138107","volume":"107","author":"RM Kanashiro-Takeuchi","year":"2010","unstructured":"Kanashiro-Takeuchi, R. M. et al. Cardioprotective effects of growth hormone-releasing hormone agonist after myocardial infarction. Proc. Natl Acad. Sci. USA 107, 2604\u20132609 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR34","doi-asserted-by":"publisher","first-page":"18611","DOI":"10.1073\/pnas.1013942107","volume":"107","author":"N Dioufa","year":"2010","unstructured":"Dioufa, N. et al. Acceleration of wound healing by growth hormone-releasing hormone and its agonists. Proc. Natl Acad. Sci. USA 107, 18611\u201318615 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR35","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1073\/pnas.1121075109","volume":"109","author":"R Lucas","year":"2012","unstructured":"Lucas, R. et al. Agonist of growth hormone-releasing hormone reduces pneumolysin-induced pulmonary permeability edema. Proc. Natl Acad. Sci. USA 109, 2084\u20132089 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR36","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrd3362","volume":"10","author":"C Grunfeld","year":"2011","unstructured":"Grunfeld, C., Dritselis, A. & Kirkpatrick, P. Tesamorelin. Nat. Rev. Drug. Discov. 10, 95\u201396 (2011).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"1052_CR37","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1001\/jama.2014.8334","volume":"312","author":"TL Stanley","year":"2014","unstructured":"Stanley, T. L. et al. Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial. JAMA 312, 380\u2013389 (2014).","journal-title":"JAMA"},{"key":"1052_CR38","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/0006-291X(90)91773-L","volume":"167","author":"K Sato","year":"1990","unstructured":"Sato, K. et al. Synthetic analogs of growth hormone-releasing factor with antagonistic activity in vitro. Biochem. Biophys. Res. Commun. 167, 360\u2013366 (1990).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1052_CR39","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0014-2999(91)90703-S","volume":"204","author":"DH Coy","year":"1991","unstructured":"Coy, D. H., Hocart, S. J. & Murphy, W. A. Human growth hormone-releasing hormone analogues with much improved in vitro growth hormone-releasing potencies in rat pituitary cells. Eur. J. Pharmacol. 204, 179\u2013185 (1991).","journal-title":"Eur. J. Pharmacol."},{"key":"1052_CR40","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1210\/endo-117-5-1759","volume":"117","author":"P Robberecht","year":"1985","unstructured":"Robberecht, P. et al. Structural requirements for the activation of rat anterior pituitary adenylate cyclase by growth hormone-releasing factor (GRF): discovery of (N-Ac-Tyr1,d-Arg2)-GRF(1-29)-NH2 as a GRF antagonist on membranes. Endocrinology 117, 1759\u20131764 (1985).","journal-title":"Endocrinology"},{"key":"1052_CR41","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1093\/jnci\/82.4.301","volume":"82","author":"MN Pollak","year":"1990","unstructured":"Pollak, M. N., Polychronakos, C. & Richard, M. Insulinlike growth factor I: a potent mitogen for human osteogenic sarcoma. J. Natl Cancer Inst. 82, 301\u2013305 (1990).","journal-title":"J. Natl Cancer Inst."},{"key":"1052_CR42","doi-asserted-by":"publisher","first-page":"4610","DOI":"10.1073\/pnas.0511348103","volume":"103","author":"M Zarandi","year":"2006","unstructured":"Zarandi, M. et al. Lipopeptide antagonists of growth hormone-releasing hormone with improved antitumor activities. Proc. Natl Acad. Sci. USA 103, 4610\u20134615 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR43","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1073\/pnas.96.2.692","volume":"96","author":"JL Varga","year":"1999","unstructured":"Varga, J. L. et al. Synthesis and biological evaluation of antagonists of growth hormone-releasing hormone with high and protracted in vivo activities. Proc. Natl Acad. Sci. USA 96, 692\u2013697 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR44","doi-asserted-by":"publisher","first-page":"170716","DOI":"10.1016\/j.peptides.2021.170716","volume":"150","author":"R Cai","year":"2022","unstructured":"Cai, R. et al. Synthesis of potent antagonists of receptors for growth hormone-releasing hormone with antitumor and anti-inflammatory activity. Peptides 150, 170716 (2022).","journal-title":"Peptides"},{"key":"1052_CR45","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1073\/pnas.1818865116","volume":"116","author":"T Villanova","year":"2019","unstructured":"Villanova, T. et al. Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma. Proc. Natl Acad. Sci. USA 116, 2226\u20132231 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR46","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1002\/ijc.31308","volume":"142","author":"H Wang","year":"2018","unstructured":"Wang, H. et al. Inhibition of experimental small-cell and non-small-cell lung cancers by novel antagonists of growth hormone-releasing hormone. Int. J. Cancer 142, 2394\u20132404 (2018).","journal-title":"Int. J. Cancer"},{"key":"1052_CR47","doi-asserted-by":"publisher","first-page":"3950","DOI":"10.3390\/cancers13163950","volume":"13","author":"I Gesmundo","year":"2021","unstructured":"Gesmundo, I. et al. Antagonists of growth hormone-releasing hormone inhibit the growth of pituitary adenoma cells by hampering oncogenic pathways and promoting apoptotic signaling. Cancers 13, 3950 (2021).","journal-title":"Cancers"},{"key":"1052_CR48","doi-asserted-by":"publisher","first-page":"14745","DOI":"10.1073\/pnas.1618582114","volume":"113","author":"J Gan","year":"2016","unstructured":"Gan, J. et al. Growth hormone-releasing hormone receptor antagonists inhibit human gastric cancer through downregulation of PAK1\u2013STAT3\/NF-\u03baB signaling. Proc. Natl Acad. Sci. USA 113, 14745\u201314750 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR49","doi-asserted-by":"publisher","first-page":"20470","DOI":"10.1073\/pnas.0811209106","volume":"105","author":"N Barabutis","year":"2008","unstructured":"Barabutis, N. & Schally, A. V. Antioxidant activity of growth hormone-releasing hormone antagonists in LNCaP human prostate cancer line. Proc. Natl Acad. Sci. USA 105, 20470\u201320475 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR50","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.3390\/cells9102331","volume":"9","author":"C Zhang","year":"2020","unstructured":"Zhang, C. et al. Growth hormone-releasing hormone in lung physiology and pulmonary disease. Cells 9, 2331 (2020).","journal-title":"Cells"},{"key":"1052_CR51","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.ebiom.2018.10.034","volume":"37","author":"N Barabutis","year":"2018","unstructured":"Barabutis, N., Schally, A. V. & Siejka, A. P53, GHRH, inflammation and cancer. EBioMedicine 37, 557\u2013562 (2018).","journal-title":"EBioMedicine"},{"key":"1052_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0260144","volume":"17","author":"B Ayhan-Sahin","year":"2022","unstructured":"Ayhan-Sahin, B., Apaydin, Z. E., Obakan-Yerlikaya, P., Arisan, E. D. & Coker-Gurkan, A. Synthesis and characterization of novel ssDNA X-aptamers targeting growth hormone releasing hormone (GHRH). PLoS ONE 17, e0260144 (2022).","journal-title":"PLoS ONE"},{"key":"1052_CR53","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.3390\/molecules24234229","volume":"24","author":"T Adachi","year":"2019","unstructured":"Adachi, T. & Nakamura, Y. Aptamers: a review of their chemical properties and modifications for therapeutic application. Molecules 24, 4229 (2019).","journal-title":"Molecules"},{"key":"1052_CR54","doi-asserted-by":"publisher","first-page":"8831","DOI":"10.3390\/ijms25168831","volume":"25","author":"E Juhasz","year":"2024","unstructured":"Juhasz, E. et al. Expression of growth hormone-releasing hormone and its receptor splice variants in a cohort of Hungarian pediatric patients with hematological and oncological disorders: a pilot study. Int. J. Mol. Sci. 25, 8831 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"1052_CR55","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2106606118","volume":"118","author":"Z Cong","year":"2021","unstructured":"Cong, Z. et al. Constitutive signal bias mediated by the human GHRHR splice variant 1. Proc. Natl Acad. Sci. USA 118, e2106606118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR56","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/360765a0","volume":"360","author":"C Lin","year":"1992","unstructured":"Lin, C., Lin, S. C., Chang, C. P. & Rosenfeld, M. G. Pit-1-dependent expression of the receptor for growth hormone releasing factor mediates pituitary cell growth. Nature 360, 765\u2013768 (1992).","journal-title":"Nature"},{"key":"1052_CR57","doi-asserted-by":"publisher","first-page":"bqad131","DOI":"10.1210\/endocr\/bqad131","volume":"164","author":"RL Gonigam","year":"2023","unstructured":"Gonigam, R. L. et al. Characterization of somatotrope cell expansion in response to GHRH in the neonatal mouse pituitary. Endocrinology 164, bqad131 (2023).","journal-title":"Endocrinology"},{"key":"1052_CR58","first-page":"582","volume":"84","author":"Z Kahan","year":"1999","unstructured":"Kahan, Z. et al. Expression of growth hormone-releasing hormone (GHRH) messenger ribonucleic acid and the presence of biologically active GHRH in human breast, endometrial, and ovarian cancers. J. Clin. Endocrinol. Metab. 84, 582\u2013589 (1999).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1052_CR59","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.regpep.2006.05.001","volume":"136","author":"C Christodoulou","year":"2006","unstructured":"Christodoulou, C. et al. Expression of growth hormone-releasing hormone (GHRH) and splice variant of GHRH receptors in normal mouse tissues. Regul. Pept. 136, 105\u2013108 (2006).","journal-title":"Regul. Pept."},{"key":"1052_CR60","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1038\/sj.bjc.6604386","volume":"98","author":"N Barabutis","year":"2008","unstructured":"Barabutis, N. & Schally, A. V. Knocking down gene expression for growth hormone-releasing hormone inhibits proliferation of human cancer cell lines. Br. J. Cancer 98, 1790\u20131796 (2008).","journal-title":"Br. J. Cancer"},{"key":"1052_CR61","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1073\/pnas.012590999","volume":"99","author":"H Kiaris","year":"2002","unstructured":"Kiaris, H. et al. Expression of a splice variant of the receptor for GHRH in 3T3 fibroblasts activates cell proliferation responses to GHRH analogs. Proc. Natl Acad. Sci. USA 99, 196\u2013200 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR62","doi-asserted-by":"publisher","first-page":"6726","DOI":"10.1073\/pnas.1913433117","volume":"117","author":"X Xiong","year":"2020","unstructured":"Xiong, X. et al. Splice variant of growth hormone-releasing hormone receptor drives esophageal squamous cell carcinoma conferring a therapeutic target. Proc. Natl Acad. Sci. USA 117, 6726\u20136732 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR63","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1210\/endo.141.6.7513","volume":"141","author":"CM Pombo","year":"2000","unstructured":"Pombo, C. M., Zalvide, J., Gaylinn, B. D. & Dieguez, C. Growth hormone-releasing hormone stimulates mitogen-activated protein kinase. Endocrinology 141, 2113\u20132119 (2000).","journal-title":"Endocrinology"},{"key":"1052_CR64","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1677\/JME-09-0121","volume":"44","author":"N Barabutis","year":"2010","unstructured":"Barabutis, N. et al. Activation of mitogen-activated protein kinases by a splice variant of GHRH receptor. J. Mol. Endocrinol. 44, 127\u2013134 (2010).","journal-title":"J. Mol. Endocrinol."},{"key":"1052_CR65","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1210\/me.2005-0001","volume":"20","author":"G Siriwardana","year":"2006","unstructured":"Siriwardana, G., Bradford, A., Coy, D. & Zeitler, P. Autocrine\/paracrine regulation of breast cancer cell proliferation by growth hormone releasing hormone via Ras, Raf, and mitogen-activated protein kinase. Mol. Endocrinol. 20, 2010\u20132019 (2006).","journal-title":"Mol. Endocrinol."},{"key":"1052_CR66","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s00018-009-0224-y","volume":"67","author":"A Siejka","year":"2010","unstructured":"Siejka, A., Schally, A. V. & Barabutis, N. Activation of Janus kinase\/signal transducer and activator of transcription 3 pathway by growth hormone-releasing hormone. Cell Mol. Life Sci. 67, 959\u2013964 (2010).","journal-title":"Cell Mol. Life Sci."},{"key":"1052_CR67","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1111\/j.1582-4934.2010.01096.x","volume":"15","author":"N Barabutis","year":"2011","unstructured":"Barabutis, N., Siejka, A. & Schally, A. V. Growth hormone releasing hormone induces the expression of nitric oxide synthase. J. Cell Mol. Med. 15, 1148\u20131155 (2011).","journal-title":"J. Cell Mol. Med."},{"key":"1052_CR68","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1002\/pros.24339","volume":"82","author":"L Munoz-Moreno","year":"2022","unstructured":"Munoz-Moreno, L., Carmena, M. J., Prieto, J. C., Schally, A. V. & Bajo, A. M. Tumorigenic transformation of human prostatic epithelial cell line RWPE-1 by growth hormone-releasing hormone (GHRH). Prostate 82, 933\u2013941 (2022).","journal-title":"Prostate"},{"key":"1052_CR69","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0167-0115(00)00166-X","volume":"96","author":"H Kiaris","year":"2001","unstructured":"Kiaris, H., Schally, A. V. & Armatis, P. Direct action of growth hormone-releasing hormone agonist JI-38 on normal human fibroblasts: evidence from studies on cell proliferation and c-myc proto-oncogene expression. Regul. Pept. 96, 119\u2013124 (2001).","journal-title":"Regul. Pept."},{"key":"1052_CR70","doi-asserted-by":"publisher","first-page":"17260","DOI":"10.1073\/pnas.1420375111","volume":"111","author":"V Florea","year":"2014","unstructured":"Florea, V. et al. Agonists of growth hormone-releasing hormone stimulate self-renewal of cardiac stem cells and promote their survival. Proc. Natl Acad. Sci. USA 111, 17260\u201317265 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR71","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2209810120","volume":"120","author":"RA Louzada","year":"2023","unstructured":"Louzada, R. A. et al. GHRH agonist MR-409 protects \u03b2-cells from streptozotocin-induced diabetes. Proc. Natl Acad. Sci. USA 120, e2209810120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR72","doi-asserted-by":"publisher","first-page":"13651","DOI":"10.1073\/pnas.1518540112","volume":"112","author":"X Zhang","year":"2015","unstructured":"Zhang, X. et al. Beneficial effects of growth hormone-releasing hormone agonists on rat INS-1 cells and on streptozotocin-induced NOD\/SCID mice. Proc. Natl Acad. Sci. USA 112, 13651\u201313656 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR73","doi-asserted-by":"publisher","first-page":"52661","DOI":"10.18632\/oncotarget.11024","volume":"7","author":"T Cui","year":"2016","unstructured":"Cui, T. et al. Agonistic analogs of growth hormone releasing hormone (GHRH) promote wound healing by stimulating the proliferation and survival of human dermal fibroblasts through ERK and AKT pathways. Oncotarget 7, 52661\u201352672 (2016).","journal-title":"Oncotarget"},{"key":"1052_CR74","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1055\/s-2007-1010774","volume":"20","author":"J Hasegawa","year":"1988","unstructured":"Hasegawa, J. et al. Positive inotropic effect of growth hormone releasing factor in the guinea-pig cardiac muscles in vitro. Horm. Metab. Res. 20, 130\u2013131 (1988).","journal-title":"Horm. Metab. Res."},{"key":"1052_CR75","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/cvr\/cvp090","volume":"83","author":"R Granata","year":"2009","unstructured":"Granata, R. et al. Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart. Cardiovasc. Res. 83, 303\u2013312 (2009).","journal-title":"Cardiovasc. Res."},{"key":"1052_CR76","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.001464","volume":"4","author":"LL Bagno","year":"2015","unstructured":"Bagno, L. L. et al. Growth hormone-releasing hormone agonists reduce myocardial infarct scar in swine with subacute ischemic cardiomyopathy. J. Am. Heart Assoc. 4, e001464 (2015).","journal-title":"J. Am. Heart Assoc."},{"key":"1052_CR77","doi-asserted-by":"publisher","first-page":"H739","DOI":"10.1152\/ajpheart.00601.2022","volume":"324","author":"RM Kanashiro-Takeuchi","year":"2023","unstructured":"Kanashiro-Takeuchi, R. M. et al. Efficacy of a growth hormone-releasing hormone agonist in a murine model of cardiometabolic heart failure with preserved ejection fraction. Am. J. Physiol. Heart Circ. Physiol. 324, H739\u2013H750 (2023).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"1052_CR78","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12020-014-0327-6","volume":"48","author":"J Isgaard","year":"2015","unstructured":"Isgaard, J., Arcopinto, M., Karason, K. & Cittadini, A. GH and the cardiovascular system: an update on a topic at heart. Endocrine 48, 25\u201335 (2015).","journal-title":"Endocrine"},{"key":"1052_CR79","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1210\/en.2012-2064","volume":"154","author":"C Penna","year":"2013","unstructured":"Penna, C. et al. GH-releasing hormone induces cardioprotection in isolated male rat heart via activation of RISK and SAFE pathways. Endocrinology 154, 1624\u20131635 (2013).","journal-title":"Endocrinology"},{"key":"1052_CR80","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.phrs.2016.07.036","volume":"111","author":"L Kiscsatari","year":"2016","unstructured":"Kiscsatari, L. et al. Protection of neonatal rat cardiac myocytes against radiation-induced damage with agonists of growth hormone-releasing hormone. Pharmacol. Res. 111, 859\u2013866 (2016).","journal-title":"Pharmacol. Res."},{"key":"1052_CR81","doi-asserted-by":"publisher","first-page":"9728","DOI":"10.18632\/oncotarget.3303","volume":"6","author":"RM Kanashiro-Takeuchi","year":"2015","unstructured":"Kanashiro-Takeuchi, R. M. et al. New therapeutic approach to heart failure due to myocardial infarction based on targeting growth hormone-releasing hormone receptor. Oncotarget 6, 9728\u20139739 (2015).","journal-title":"Oncotarget"},{"key":"1052_CR82","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1073\/pnas.1119203109","volume":"109","author":"RM Kanashiro-Takeuchi","year":"2012","unstructured":"Kanashiro-Takeuchi, R. M. et al. Activation of growth hormone releasing hormone (GHRH) receptor stimulates cardiac reverse remodeling after myocardial infarction (MI). Proc. Natl Acad. Sci. USA 109, 559\u2013563 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR83","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1161\/CIRCRESAHA.119.313572","volume":"124","author":"MA Pfeffer","year":"2019","unstructured":"Pfeffer, M. A., Shah, A. M. & Borlaug, B. A. Heart failure with preserved ejection fraction in perspective. Circ. Res. 124, 1598\u20131617 (2019).","journal-title":"Circ. Res."},{"key":"1052_CR84","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2019835118","volume":"118","author":"AC Rieger","year":"2021","unstructured":"Rieger, A. C. et al. Growth hormone-releasing hormone agonists ameliorate chronic kidney disease-induced heart failure with preserved ejection fraction. Proc. Natl Acad. Sci. USA 118, e2019835118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR85","doi-asserted-by":"publisher","first-page":"3586","DOI":"10.1093\/cvr\/cvac098","volume":"118","author":"RA Dulce","year":"2023","unstructured":"Dulce, R. A. et al. Synthetic growth hormone-releasing hormone agonist ameliorates the myocardial pathophysiology characteristic of heart failure with preserved ejection fraction. Cardiovasc. Res. 118, 3586\u20133601 (2023).","journal-title":"Cardiovasc. Res."},{"key":"1052_CR86","doi-asserted-by":"publisher","first-page":"12033","DOI":"10.1073\/pnas.1712612114","volume":"114","author":"I Gesmundo","year":"2017","unstructured":"Gesmundo, I. et al. Growth hormone-releasing hormone attenuates cardiac hypertrophy and improves heart function in pressure overload-induced heart failure. Proc. Natl Acad. Sci. USA 114, 12033\u201312038 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR87","doi-asserted-by":"publisher","first-page":"8197","DOI":"10.1002\/jcp.30490","volume":"236","author":"P Xiang","year":"2021","unstructured":"Xiang, P. et al. Improvement of cardiac and systemic function in old mice by agonist of growth hormone-releasing hormone. J. Cell Physiol. 236, 8197\u20138207 (2021).","journal-title":"J. Cell Physiol."},{"key":"1052_CR88","doi-asserted-by":"publisher","first-page":"2","DOI":"10.12997\/jla.2024.13.1.2","volume":"13","author":"B Tomlinson","year":"2024","unstructured":"Tomlinson, B., Wu, Q. Y., Zhong, Y. M. & Li, Y. H. Advances in dyslipidaemia treatments: focusing on ApoC3 and ANGPTL3 inhibitors. J. Lipid Atheroscler. 13, 2\u201320 (2024).","journal-title":"J. Lipid Atheroscler."},{"key":"1052_CR89","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0179538","volume":"12","author":"DR Clemmons","year":"2017","unstructured":"Clemmons, D. R., Miller, S. & Mamputu, J. C. Safety and metabolic effects of tesamorelin, a growth hormone-releasing factor analogue, in patients with type 2 diabetes: a randomized, placebo-controlled trial. PLoS ONE\u00a012, e0179538 (2017).","journal-title":"PLoS ONE"},{"key":"1052_CR90","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1161\/CIRCRESAHA.117.312418","volume":"122","author":"J Shen","year":"2018","unstructured":"Shen, J. et al. Regulation of vascular calcification by growth hormone-releasing hormone and its agonists. Circ. Res. 122, 1395\u20131408 (2018).","journal-title":"Circ. Res."},{"key":"1052_CR91","doi-asserted-by":"publisher","first-page":"1102525","DOI":"10.3389\/fcvm.2023.1102525","volume":"10","author":"HL Ren","year":"2023","unstructured":"Ren, H. L. et al. Growth hormone-releasing hormone agonist attenuates vascular calcification in diabetic db\/db mice. Front. Cardiovasc. Med. 10, 1102525 (2023).","journal-title":"Front. Cardiovasc. Med."},{"key":"1052_CR92","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1073\/pnas.1220185110","volume":"110","author":"SA Gomes","year":"2013","unstructured":"Gomes, S. A. et al. S-nitrosoglutathione reductase (GSNOR) enhances vasculogenesis by mesenchymal stem cells. Proc. Natl Acad. Sci. USA 110, 2834\u20132839 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR93","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1161\/ATVBAHA.116.307126","volume":"36","author":"Q Ma","year":"2016","unstructured":"Ma, Q. et al. Profound actions of an agonist of growth hormone-releasing hormone on angiogenic therapy by mesenchymal stem cells. Arterioscler. Thromb. Vasc. Biol. 36, 663\u2013672 (2016).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1052_CR94","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s40618-019-01109-3","volume":"43","author":"Z Li","year":"2020","unstructured":"Li, Z. et al. Growth hormone-releasing hormone promotes therapeutic effects of peripheral blood endothelial progenitor cells in ischemic repair. J. Endocrinol. Invest. 43, 315\u2013328 (2020).","journal-title":"J. Endocrinol. Invest."},{"key":"1052_CR95","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1046\/j.1464-5491.2003.00827.x","volume":"20","author":"RI Holt","year":"2003","unstructured":"Holt, R. I., Simpson, H. L. & Sonksen, P. H. The role of the growth hormone-insulin-like growth factor axis in glucose homeostasis. Diabet. Med. 20, 3\u201315 (2003).","journal-title":"Diabet. Med."},{"key":"1052_CR96","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1210\/er.2013-1071","volume":"35","author":"P Kamenicky","year":"2014","unstructured":"Kamenicky, P., Mazziotti, G., Lombes, M., Giustina, A. & Chanson, P. Growth hormone, insulin-like growth factor-1, and the kidney: pathophysiological and clinical implications. Endocr. Rev. 35, 234\u2013281 (2014).","journal-title":"Endocr. Rev."},{"key":"1052_CR97","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1073\/pnas.1525520113","volume":"113","author":"MJ Romero","year":"2016","unstructured":"Romero, M. J. et al. Role of growth hormone-releasing hormone in dyslipidemia associated with experimental type 1 diabetes. Proc. Natl Acad. Sci. USA 113, 1895\u20131900 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR98","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.133488","volume":"5","author":"M Bayne","year":"2020","unstructured":"Bayne, M. et al. Repeated hypoglycemia remodels neural inputs and disrupts mitochondrial function to blunt glucose-inhibited GHRH neuron responsiveness. JCI Insight 5, e133488 (2020).","journal-title":"JCI Insight"},{"key":"1052_CR99","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fendo.2016.00129","volume":"7","author":"LE Fridlyand","year":"2016","unstructured":"Fridlyand, L. E., Tamarina, N. A., Schally, A. V. & Philipson, L. H. Growth hormone-releasing hormone in diabetes. Front. Endocrinol. 7, 129 (2016).","journal-title":"Front. Endocrinol."},{"key":"1052_CR100","doi-asserted-by":"publisher","first-page":"13722","DOI":"10.1073\/pnas.1110965108","volume":"108","author":"J Schmid","year":"2011","unstructured":"Schmid, J. et al. Modulation of pancreatic islets-stress axis by hypothalamic releasing hormones and 11\u03b2-hydroxysteroid dehydrogenase. Proc. Natl Acad. Sci. USA 108, 13722\u201313727 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR101","doi-asserted-by":"publisher","first-page":"111379","DOI":"10.1016\/j.mce.2021.111379","volume":"535","author":"K Rodrigues-Dos-Santos","year":"2021","unstructured":"Rodrigues-Dos-Santos, K. et al. Effects of growth hormone-releasing hormone agonistic analog MR-409 on insulin-secreting cells under cyclopiazonic acid-induced endoplasmic reticulum stress. Mol. Cell Endocrinol. 535, 111379 (2021).","journal-title":"Mol. Cell Endocrinol."},{"key":"1052_CR102","doi-asserted-by":"publisher","first-page":"bqac184","DOI":"10.1210\/endocr\/bqac184","volume":"164","author":"A Kulkarni","year":"2022","unstructured":"Kulkarni, A., Muralidharan, C., May, S. C., Tersey, S. A. & Mirmira, R. G. Inside the \u03b2 cell: molecular stress response pathways in diabetes pathogenesis. Endocrinology 164, bqac184 (2022).","journal-title":"Endocrinology"},{"key":"1052_CR103","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1007\/s00125-023-05906-7","volume":"66","author":"DJ Drucker","year":"2023","unstructured":"Drucker, D. J. & Holst, J. J. The expanding incretin universe: from basic biology to clinical translation. Diabetologia 66, 1765\u20131779 (2023).","journal-title":"Diabetologia"},{"key":"1052_CR104","doi-asserted-by":"publisher","first-page":"145","DOI":"10.6065\/apem.2017.22.3.145","volume":"22","author":"SH Kim","year":"2017","unstructured":"Kim, S. H. & Park, M. J. Effects of growth hormone on glucose metabolism and insulin resistance in human. Ann. Pediatr. Endocrinol. Metab. 22, 145\u2013152 (2017).","journal-title":"Ann. Pediatr. Endocrinol. Metab."},{"key":"1052_CR105","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.3390\/cells12202423","volume":"12","author":"Z Czarnecka","year":"2023","unstructured":"Czarnecka, Z., Dadheech, N., Razavy, H., Pawlick, R. & Shapiro, A. M. J. The current status of allogenic islet cell transplantation. Cells 12, 2423 (2023).","journal-title":"Cells"},{"key":"1052_CR106","doi-asserted-by":"publisher","first-page":"5022","DOI":"10.1073\/pnas.1201868109","volume":"109","author":"B Ludwig","year":"2012","unstructured":"Ludwig, B. et al. Improvement of islet function in a bioartificial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist. Proc. Natl Acad. Sci. USA 109, 5022\u20135027 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR107","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1073\/pnas.1221505110","volume":"110","author":"U Schubert","year":"2013","unstructured":"Schubert, U. et al. Transplantation of pancreatic islets to adrenal gland is promoted by agonists of growth-hormone-releasing hormone. Proc. Natl Acad. Sci. USA 110, 2288\u20132293 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR108","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41573-021-00337-8","volume":"21","author":"TD Muller","year":"2022","unstructured":"Muller, T. D., Bluher, M., Tschop, M. H. & DiMarchi, R. D. Anti-obesity drug discovery: advances and challenges. Nat. Rev. Drug. Discov. 21, 201\u2013223 (2022).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"1052_CR109","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ghir.2014.12.005","volume":"25","author":"TL Stanley","year":"2015","unstructured":"Stanley, T. L. & Grinspoon, S. K. Effects of growth hormone-releasing hormone on visceral fat, metabolic, and cardiovascular indices in human studies. Growth Horm. IGF Res. 25, 59\u201365 (2015).","journal-title":"Growth Horm. IGF Res."},{"key":"1052_CR110","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1038\/ijo.2017.145","volume":"41","author":"F Rodr\u00edguez-Pacheco","year":"2017","unstructured":"Rodr\u00edguez-Pacheco, F. et al. Growth hormone-releasing hormone is produced by adipocytes and regulates lipolysis through growth hormone receptor. Int. J. Obes. 41, 1547\u20131555 (2017).","journal-title":"Int. J. Obes."},{"key":"1052_CR111","doi-asserted-by":"publisher","first-page":"578966","DOI":"10.3389\/fphys.2020.578966","volume":"11","author":"L Recinella","year":"2020","unstructured":"Recinella, L. et al. Adipokines: new potential therapeutic target for obesity and metabolic, rheumatic, and cardiovascular diseases. Front. Physiol. 11, 578966 (2020).","journal-title":"Front. Physiol."},{"key":"1052_CR112","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3390\/nu15051077","volume":"15","author":"L Decourtye-Espiard","year":"2023","unstructured":"Decourtye-Espiard, L. et al. Stimulation of GHRH neuron axon growth by leptin and impact of nutrition during suckling in mice. Nutrients 15, 1077 (2023).","journal-title":"Nutrients"},{"key":"1052_CR113","doi-asserted-by":"publisher","first-page":"170582","DOI":"10.1016\/j.peptides.2021.170582","volume":"142","author":"L Recinella","year":"2021","unstructured":"Recinella, L. et al. Growth hormone-releasing hormone antagonistic analog MIA-690 stimulates food intake in mice. Peptides 142, 170582 (2021).","journal-title":"Peptides"},{"key":"1052_CR114","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.molmet.2015.03.005","volume":"4","author":"TD Muller","year":"2015","unstructured":"Muller, T. D. et al. Ghrelin. Mol. Metab. 4, 437\u2013460 (2015).","journal-title":"Mol. Metab."},{"key":"1052_CR115","doi-asserted-by":"publisher","first-page":"20452","DOI":"10.1073\/pnas.0811680106","volume":"105","author":"FF Casanueva","year":"2008","unstructured":"Casanueva, F. F. et al. Growth hormone-releasing hormone as an agonist of the ghrelin receptor GHS-R1a. Proc. Natl Acad. Sci. USA 105, 20452\u201320457 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR116","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.neuroscience.2023.08.006","volume":"529","author":"S Sapkota","year":"2023","unstructured":"Sapkota, S. et al. GHRH neurons from the ventromedial hypothalamic nucleus provide dynamic and sex-specific input to the brain glucose-regulatory network. Neuroscience 529, 73\u201387 (2023).","journal-title":"Neuroscience"},{"key":"1052_CR117","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1152\/physrev.1999.79.2.511","volume":"79","author":"EE Muller","year":"1999","unstructured":"Muller, E. E., Locatelli, V. & Cocchi, D. Neuroendocrine control of growth hormone secretion. Physiol. Rev. 79, 511\u2013607 (1999).","journal-title":"Physiol. Rev."},{"key":"1052_CR118","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.neurobiolaging.2005.01.010","volume":"27","author":"MV Vitiello","year":"2006","unstructured":"Vitiello, M. V. et al. Growth hormone releasing hormone improves the cognition of healthy older adults. Neurobiol. Aging 27, 318\u2013323 (2006).","journal-title":"Neurobiol. Aging"},{"key":"1052_CR119","doi-asserted-by":"publisher","first-page":"406","DOI":"10.21037\/atm-20-6561","volume":"9","author":"Y Chang","year":"2021","unstructured":"Chang, Y. et al. A potentially effective drug for patients with recurrent glioma: sermorelin. Ann. Transl. Med. 9, 406 (2021).","journal-title":"Ann. Transl. Med."},{"key":"1052_CR120","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1001\/archneurol.2012.1970","volume":"69","author":"LD Baker","year":"2012","unstructured":"Baker, L. D. et al. Effects of growth hormone-releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial. Arch. Neurol. 69, 1420\u20131429 (2012).","journal-title":"Arch. Neurol."},{"key":"1052_CR121","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1001\/jamaneurol.2013.1425","volume":"70","author":"SD Friedman","year":"2013","unstructured":"Friedman, S. D. et al. Growth hormone-releasing hormone effects on brain \u03b3-aminobutyric acid levels in mild cognitive impairment and healthy aging. JAMA Neurol. 70, 883\u2013890 (2013).","journal-title":"JAMA Neurol."},{"key":"1052_CR122","doi-asserted-by":"publisher","first-page":"22272","DOI":"10.1073\/pnas.1016369107","volume":"107","author":"WA Banks","year":"2010","unstructured":"Banks, W. A. et al. Effects of a growth hormone-releasing hormone antagonist on telomerase activity, oxidative stress, longevity, and aging in mice. Proc. Natl Acad. Sci. USA 107, 22272\u201322277 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR123","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.bbr.2011.05.036","volume":"224","author":"G Telegdy","year":"2011","unstructured":"Telegdy, G., Tanaka, M. & Schally, A. V. Effects of the growth hormone-releasing hormone (GH-RH) antagonist on brain functions in mice. Behav. Brain Res. 224, 155\u2013158 (2011).","journal-title":"Behav. Brain Res."},{"key":"1052_CR124","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-57292-z","volume":"10","author":"L Recinella","year":"2020","unstructured":"Recinella, L. et al. Antinflammatory, antioxidant, and behavioral effects induced by administration of growth hormone-releasing hormone analogs in mice. Sci. Rep. 10, 732 (2020).","journal-title":"Sci. Rep."},{"key":"1052_CR125","doi-asserted-by":"publisher","first-page":"7465","DOI":"10.1038\/s41380-021-01228-5","volume":"26","author":"L Recinella","year":"2021","unstructured":"Recinella, L. et al. Effects of growth hormone-releasing hormone receptor antagonist MIA-602 in mice with emotional disorders: a potential treatment for PTSD. Mol. Psychiatry 26, 7465\u20137474 (2021).","journal-title":"Mol. Psychiatry"},{"key":"1052_CR126","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.3390\/cells12222615","volume":"12","author":"L Recinella","year":"2023","unstructured":"Recinella, L. et al. Effects of GHRH deficiency and GHRH antagonism on emotional disorders in mice. Cells 12, 2615 (2023).","journal-title":"Cells"},{"key":"1052_CR127","doi-asserted-by":"publisher","first-page":"755","DOI":"10.18632\/aging.100504","volume":"4","author":"M Jaszberenyi","year":"2012","unstructured":"Jaszberenyi, M. et al. Beneficial effects of novel antagonists of GHRH in different models of Alzheimer\u2019s disease. Aging 4, 755\u2013767 (2012).","journal-title":"Aging"},{"key":"1052_CR128","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.pharep.2018.06.001","volume":"70","author":"EA Oglodek","year":"2018","unstructured":"Oglodek, E. A. & Just, M. J. The association between inflammatory markers (iNOS, HO-1, IL-33, MIP-1\u03b2) and depression with and without posttraumatic stress disorder. Pharmacol. Rep. 70, 1065\u20131072 (2018).","journal-title":"Pharmacol. Rep."},{"key":"1052_CR129","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/mp.2011.121","volume":"17","author":"JJ Rakofsky","year":"2012","unstructured":"Rakofsky, J. J., Ressler, K. J. & Dunlop, B. W. BDNF function as a potential mediator of bipolar disorder and post-traumatic stress disorder comorbidity. Mol. Psychiatry 17, 22\u201335 (2012).","journal-title":"Mol. Psychiatry"},{"key":"1052_CR130","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023435","volume":"6","author":"M Hallschmid","year":"2011","unstructured":"Hallschmid, M., Wilhelm, I., Michel, C., Perras, B. & Born, J. A role for central nervous growth hormone-releasing hormone signaling in the consolidation of declarative memories. PLoS ONE\u00a06, e23435 (2011).","journal-title":"PLoS ONE"},{"key":"1052_CR131","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nn1656","volume":"9","author":"S Diano","year":"2006","unstructured":"Diano, S. et al. Ghrelin controls hippocampal spine synapse density and memory performance. Nat. Neurosci. 9, 381\u2013388 (2006).","journal-title":"Nat. Neurosci."},{"key":"1052_CR132","first-page":"OC13.4","volume":"99","author":"F Pedrolli","year":"2024","unstructured":"Pedrolli, F. et al. Protective effect of growth hormone-releasing hormone (GHRH) and its agonistic analog MR-409 in Alzheimer\u2019s disease [abstract]. Endocr. Abstr. 99, OC13.4 (2024).","journal-title":"Endocr. Abstr."},{"key":"1052_CR133","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1210\/EN.2015-1098","volume":"156","author":"D Gallo","year":"2015","unstructured":"Gallo, D. et al. GH-releasing hormone promotes survival and prevents TNF-\u03b1-induced apoptosis and atrophy in C2C12 myotubes. Endocrinology 156, 3239\u20133252 (2015).","journal-title":"Endocrinology"},{"key":"1052_CR134","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41582-020-00413-4","volume":"16","author":"E Mercuri","year":"2020","unstructured":"Mercuri, E., Pera, M. C., Scoto, M., Finkel, R. & Muntoni, F. Spinal muscular atrophy \u2013 insights and challenges in the treatment era. Nat. Rev. Neurol. 16, 706\u2013715 (2020).","journal-title":"Nat. Rev. Neurol."},{"key":"1052_CR135","doi-asserted-by":"publisher","first-page":"66796","DOI":"10.18632\/oncotarget.18358","volume":"8","author":"SR Dubovy","year":"2017","unstructured":"Dubovy, S. R. et al. Expression of hypothalamic neurohormones and their receptors in the human eye. Oncotarget 8, 66796\u201366814 (2017).","journal-title":"Oncotarget"},{"key":"1052_CR136","doi-asserted-by":"publisher","first-page":"13248","DOI":"10.1073\/pnas.1718592114","volume":"114","author":"MC Thounaojam","year":"2017","unstructured":"Thounaojam, M. C. et al. Protective effects of agonists of growth hormone-releasing hormone (GHRH) in early experimental diabetic retinopathy. Proc. Natl Acad. Sci. USA 114, 13248\u201313253 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR137","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1920834118","volume":"118","author":"LP Cen","year":"2021","unstructured":"Cen, L. P. et al. Agonist of growth hormone-releasing hormone enhances retinal ganglion cell protection induced by macrophages after optic nerve injury. Proc. Natl Acad. Sci. USA 118, e1920834118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR138","doi-asserted-by":"publisher","first-page":"6067","DOI":"10.1073\/pnas.1904532117","volume":"117","author":"WC Liang","year":"2020","unstructured":"Liang, W. C. et al. Signaling mechanisms of growth hormone-releasing hormone receptor in LPS-induced acute ocular inflammation. Proc. Natl Acad. Sci. USA 117, 6067\u20136074 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR139","doi-asserted-by":"publisher","first-page":"18303","DOI":"10.1073\/pnas.1421815112","volume":"111","author":"YJ Qin","year":"2014","unstructured":"Qin, Y. J. et al. Antagonist of GH-releasing hormone receptors alleviates experimental ocular inflammation. Proc. Natl Acad. Sci. USA 111, 18303\u201318308 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR140","doi-asserted-by":"publisher","first-page":"14396","DOI":"10.1073\/pnas.1617427113","volume":"113","author":"WK Chu","year":"2016","unstructured":"Chu, W. K. et al. Antagonists of growth hormone-releasing hormone receptor induce apoptosis specifically in retinoblastoma cells. Proc. Natl Acad. Sci. USA 113, 14396\u201314401 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR141","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39023-1","volume":"14","author":"L Du","year":"2023","unstructured":"Du, L. et al. Growth hormone releasing hormone signaling promotes Th17 cell differentiation and autoimmune inflammation. Nat. Commun. 14, 3298 (2023).","journal-title":"Nat. Commun."},{"key":"1052_CR142","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.neuron.2010.11.032","volume":"68","author":"CB Saper","year":"2010","unstructured":"Saper, C. B., Fuller, P. M., Pedersen, N. P., Lu, J. & Scammell, T. E. Sleep state switching. Neuron 68, 1023\u20131042 (2010).","journal-title":"Neuron"},{"key":"1052_CR143","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1523\/JNEUROSCI.19-06-02187.1999","volume":"19","author":"J Zhang","year":"1999","unstructured":"Zhang, J. et al. Intrapreoptic microinjection of GHRH or its antagonist alters sleep in rats. J. Neurosci. 19, 2187\u20132194 (1999).","journal-title":"J. Neurosci."},{"key":"1052_CR144","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.smrv.2004.03.005","volume":"8","author":"F Obal Jr.","year":"2004","unstructured":"Obal, F. Jr. & Krueger, J. M. GHRH and sleep. Sleep. Med. Rev. 8, 367\u2013377 (2004).","journal-title":"Sleep. Med. Rev."},{"key":"1052_CR145","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1159\/000126275","volume":"56","author":"A Steiger","year":"1992","unstructured":"Steiger, A. et al. Effects of growth hormone-releasing hormone and somatostatin on sleep EEG and nocturnal hormone secretion in male controls. Neuroendocrinology 56, 566\u2013573 (1992).","journal-title":"Neuroendocrinology"},{"key":"1052_CR146","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrneurol.2013.269","volume":"10","author":"YE Ju","year":"2014","unstructured":"Ju, Y. E., Lucey, B. P. & Holtzman, D. M. Sleep and Alzheimer disease pathology \u2013 a bidirectional relationship. Nat. Rev. Neurol. 10, 115\u2013119 (2014).","journal-title":"Nat. Rev. Neurol."},{"key":"1052_CR147","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.bbi.2014.09.005","volume":"47","author":"F Liao","year":"2015","unstructured":"Liao, F., Zhang, T. J., Mahan, T. E., Jiang, H. & Holtzman, D. M. Effects of growth hormone-releasing hormone on sleep and brain interstitial fluid amyloid-\u03b2 in an APP transgenic mouse model. Brain Behav. Immun. 47, 163\u2013171 (2015).","journal-title":"Brain Behav. Immun."},{"key":"1052_CR148","first-page":"P436","volume":"81","author":"F Pedrolli","year":"2022","unstructured":"Pedrolli, F. et al. Growth hormone-releasing hormone (GHRH) promotes survival and proliferation of neural stem cells and reduces amyloid-\u03b2-induced toxicity [abstract]. Endocr. Abstr. 81, P436 (2022).","journal-title":"Endocr. Abstr."},{"key":"1052_CR149","doi-asserted-by":"publisher","first-page":"113545","DOI":"10.1016\/j.ygcen.2020.113545","volume":"296","author":"X Lyu","year":"2020","unstructured":"Lyu, X., Wang, G., Pi, Z. & Wu, L. Acute sleep deprivation leads to growth hormone (GH) resistance in rats. Gen. Comp. Endocrinol. 296, 113545 (2020).","journal-title":"Gen. Comp. Endocrinol."},{"key":"1052_CR150","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/314167a0","volume":"314","author":"FJ Vaccarino","year":"1985","unstructured":"Vaccarino, F. J., Bloom, F. E., Rivier, J., Vale, W. & Koob, G. F. Stimulation of food intake in rats by centrally administered hypothalamic growth hormone-releasing factor. Nature 314, 167\u2013168 (1985).","journal-title":"Nature"},{"key":"1052_CR151","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/0006-8993(85)90792-9","volume":"340","author":"T Imaki","year":"1985","unstructured":"Imaki, T. et al. The satiety effect of growth hormone-releasing factor in rats. Brain Res. 340, 186\u2013188 (1985).","journal-title":"Brain Res."},{"key":"1052_CR152","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1677\/joe.0.1690205","volume":"169","author":"R Lathe","year":"2001","unstructured":"Lathe, R. Hormones and the hippocampus. J. Endocrinol. 169, 205\u2013231 (2001).","journal-title":"J. Endocrinol."},{"key":"1052_CR153","doi-asserted-by":"publisher","first-page":"T123","DOI":"10.1530\/JOE-15-0120","volume":"226","author":"PG Murray","year":"2015","unstructured":"Murray, P. G., Higham, C. E. & Clayton, P. E. 60 years of neuroendocrinology: the hypothalamo-GH axis: the past 60 years. J. Endocrinol. 226, T123\u2013T140 (2015).","journal-title":"J. Endocrinol."},{"key":"1052_CR154","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.neuroscience.2013.11.011","volume":"258","author":"J Olsen","year":"2014","unstructured":"Olsen, J. et al. Intimate associations between the endogenous opiate systems and the growth hormone-releasing hormone system in the human hypothalamus. Neuroscience 258, 238\u2013245 (2014).","journal-title":"Neuroscience"},{"key":"1052_CR155","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1210\/endo-129-3-1275","volume":"129","author":"J Honegger","year":"1991","unstructured":"Honegger, J. et al. Interleukin-\u03b2 modulates the acute release of growth hormone-releasing hormone and somatostatin from rat hypothalamus in vitro, whereas tumor necrosis factor and interleukin-6 have no effect. Endocrinology 129, 1275\u20131282 (1991).","journal-title":"Endocrinology"},{"key":"1052_CR156","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.pnpbp.2004.01.012","volume":"28","author":"RS Talhouk","year":"2004","unstructured":"Talhouk, R. S., Saade, N. E., Mouneimne, G., Masaad, C. A. & Safieh-Garabedian, B. Growth hormone releasing hormone reverses endotoxin-induced localized inflammatory hyperalgesia without reducing the upregulated cytokines, nerve growth factor and gelatinase activity. Prog. Neuropsychopharmacol. Biol. Psychiatry 28, 625\u2013631 (2004).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"1052_CR157","doi-asserted-by":"publisher","first-page":"106362","DOI":"10.1016\/j.prostaglandins.2019.106362","volume":"144","author":"S Leone","year":"2019","unstructured":"Leone, S. et al. Increased pain and inflammatory sensitivity in growth hormone-releasing hormone (GHRH) knockout mice. Prostaglandins Other Lipid Mediat. 144, 106362 (2019).","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"1052_CR158","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-81778-4","volume":"11","author":"L Recinella","year":"2021","unstructured":"Recinella, L. et al. Protective effects of growth hormone-releasing hormone analogs in DSS-induced colitis in mice. Sci. Rep. 11, 2530 (2021).","journal-title":"Sci. Rep."},{"key":"1052_CR159","doi-asserted-by":"publisher","first-page":"70ra13","DOI":"10.1126\/scitranslmed.3001845","volume":"3","author":"J Guevara-Aguirre","year":"2011","unstructured":"Guevara-Aguirre, J. et al. Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Sci. Transl. Med. 3, 70ra13 (2011).","journal-title":"Sci. Transl. Med."},{"key":"1052_CR160","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1111\/acel.12213","volume":"13","author":"S Milman","year":"2014","unstructured":"Milman, S. et al. Low insulin-like growth factor-1 level predicts survival in humans with exceptional longevity. Aging Cell 13, 769\u2013771 (2014).","journal-title":"Aging Cell"},{"key":"1052_CR161","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.cmet.2016.05.014","volume":"23","author":"S Milman","year":"2016","unstructured":"Milman, S., Huffman, D. M. & Barzilai, N. The somatotropic axis in human aging: framework for the current state of knowledge and future research. Cell Metab. 23, 980\u2013989 (2016).","journal-title":"Cell Metab."},{"key":"1052_CR162","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3109\/08923973.2010.510844","volume":"33","author":"M Iovino","year":"2011","unstructured":"Iovino, M. et al. Difference in growth hormone response to growth hormone-releasing hormone (GHRH) testing following GHRH subacute treatment in normal aging and growth hormone-deficient adults: possible perspectives for therapeutic use of GHRH or its analogs in elderly subjects? Immunopharmacol. Immunotoxicol. 33, 334\u2013337 (2011).","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"1052_CR163","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cellimm.2013.04.009","volume":"282","author":"DA Weigent","year":"2013","unstructured":"Weigent, D. A. Expression of lymphocyte-derived growth hormone (GH) and GH-releasing hormone receptors in aging rats. Cell Immunol. 282, 71\u201378 (2013).","journal-title":"Cell Immunol."},{"key":"1052_CR164","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nrendo.2013.78","volume":"9","author":"F Nyberg","year":"2013","unstructured":"Nyberg, F. & Hallberg, M. Growth hormone and cognitive function. Nat. Rev. Endocrinol. 9, 357\u2013365 (2013).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1052_CR165","doi-asserted-by":"publisher","first-page":"B106","DOI":"10.1093\/gerona\/55.2.B106","volume":"55","author":"PL Thornton","year":"2000","unstructured":"Thornton, P. L., Ingram, R. L. & Sonntag, W. E. Chronic [D-Ala2]-growth hormone-releasing hormone administration attenuates age-related deficits in spatial memory. J. Gerontol. A Biol. Sci. Med. Sci. 55, B106\u2013B112 (2000).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"1052_CR166","doi-asserted-by":"publisher","first-page":"101429","DOI":"10.1016\/j.ghir.2021.101429","volume":"60-61","author":"R Ye","year":"2021","unstructured":"Ye, R. et al. GHRH expression plasmid improves osteoporosis and skin damage in aged mice. Growth Horm. IGF Res. 60-61, 101429 (2021).","journal-title":"Growth Horm. IGF Res."},{"key":"1052_CR167","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1152\/physrev.00006.2012","volume":"93","author":"A Bartke","year":"2013","unstructured":"Bartke, A., Sun, L. Y. & Longo, V. Somatotropic signaling: trade-offs between growth, reproductive development, and longevity. Physiol. Rev. 93, 571\u2013598 (2013).","journal-title":"Physiol. Rev."},{"key":"1052_CR168","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.01098","volume":"2","author":"LY Sun","year":"2013","unstructured":"Sun, L. Y. et al. Growth hormone-releasing hormone disruption extends lifespan and regulates response to caloric restriction in mice. Elife 2, e01098 (2013).","journal-title":"Elife"},{"key":"1052_CR169","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13985","volume":"22","author":"AT Lasher","year":"2023","unstructured":"Lasher, A. T. & Sun, L. Y. Distinct physiological characteristics and altered glucagon signaling in GHRH knockout mice: implications for longevity. Aging Cell 22, e13985 (2023).","journal-title":"Aging Cell"},{"key":"1052_CR170","doi-asserted-by":"publisher","DOI":"10.1111\/acel.14226","volume":"23","author":"AT Lasher","year":"2024","unstructured":"Lasher, A. T., Wang, L., Hyun, J., Summers, S. A. & Sun, L. Y. Unveiling ceramide dynamics: shedding light on healthy aging in growth hormone-releasing hormone knockout mice. Aging Cell 23, e14226 (2024).","journal-title":"Aging Cell"},{"key":"1052_CR171","doi-asserted-by":"publisher","DOI":"10.1111\/acel.14238","volume":"23","author":"J Adkins-Jablonsky","year":"2024","unstructured":"Adkins-Jablonsky, J., Lasher, A. T., Patki, A., Nagarajan, A. & Sun, L. Y. Growth hormone-releasing hormone deficiency confers extended lifespan and metabolic resilience during high-fat feeding in mid and late life. Aging Cell 23, e14238 (2024).","journal-title":"Aging Cell"},{"key":"1052_CR172","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.18632\/aging.102822","volume":"12","author":"JM Hoffman","year":"2020","unstructured":"Hoffman, J. M. et al. Transcriptomic and metabolomic profiling of long-lived growth hormone releasing hormone knock-out mice: evidence for altered mitochondrial function and amino acid metabolism. Aging 12, 3473\u20133485 (2020).","journal-title":"Aging"},{"key":"1052_CR173","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ghir.2014.06.004","volume":"24","author":"S Leone","year":"2014","unstructured":"Leone, S. et al. Behavioural phenotyping of male growth hormone-releasing hormone (GHRH) knockout mice. Growth Horm. IGF Res. 24, 192\u2013197 (2014).","journal-title":"Growth Horm. IGF Res."},{"key":"1052_CR174","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1530\/EC-18-0165","volume":"7","author":"S Leone","year":"2018","unstructured":"Leone, S. et al. Behavioural phenotyping, learning and memory in young and aged growth hormone-releasing hormone-knockout mice. Endocr. Connect. 7, 924\u2013931 (2018).","journal-title":"Endocr. Connect."},{"key":"1052_CR175","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11154-020-09591-4","volume":"22","author":"MH Aguiar-Oliveira","year":"2021","unstructured":"Aguiar-Oliveira, M. H. & Salvatori, R. Disruption of the GHRH receptor and its impact on children and adults: the Itabaianinha syndrome. Rev. Endocr. Metab. Disord. 22, 81\u201389 (2021).","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"1052_CR176","volume":"13","author":"VO Batista","year":"2024","unstructured":"Batista, V. O. et al. Cognitive performance during senescence in untreated congenital isolated GH deficiency. Endocr. Connect. 13, e230401 (2024).","journal-title":"Endocr. Connect."},{"key":"1052_CR177","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1210\/er.2018-00216","volume":"40","author":"MH Aguiar-Oliveira","year":"2019","unstructured":"Aguiar-Oliveira, M. H. & Bartke, A. Growth hormone deficiency: health and longevity. Endocr. Rev. 40, 575\u2013601 (2019).","journal-title":"Endocr. Rev."},{"key":"1052_CR178","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s12672-015-0217-2","volume":"6","author":"P Catanuto","year":"2015","unstructured":"Catanuto, P. et al. Expression of receptors for pituitary-type growth hormone-releasing hormone (pGHRH-R) in human papillary thyroid cancer cells: effects of GHRH antagonists on matrix metalloproteinase-2. Horm. Cancer 6, 100\u2013106 (2015).","journal-title":"Horm. Cancer"},{"key":"1052_CR179","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1073\/pnas.0610860104","volume":"104","author":"S Buchholz","year":"2007","unstructured":"Buchholz, S. et al. Potentiation of mammary cancer inhibition by combination of antagonists of growth hormone-releasing hormone with docetaxel. Proc. Natl Acad. Sci. USA 104, 1943\u20131946 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR180","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-8-54","volume":"8","author":"J Guo","year":"2010","unstructured":"Guo, J., Schally, A. V., Zarandi, M., Varga, J. & Leung, P. C. Antiproliferative effect of growth hormone-releasing hormone (GHRH) antagonist on ovarian cancer cells through the EGFR-Akt pathway. Reprod. Biol. Endocrinol. 8, 54 (2010).","journal-title":"Reprod. Biol. Endocrinol."},{"key":"1052_CR181","doi-asserted-by":"publisher","first-page":"3614","DOI":"10.1210\/jc.2004-2179","volume":"90","author":"JB Engel","year":"2005","unstructured":"Engel, J. B. et al. Inhibition of growth of experimental human endometrial cancer by an antagonist of growth hormone-releasing hormone. J. Clin. Endocrinol. Metab. 90, 3614\u20133621 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1052_CR182","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1073\/pnas.1323102111","volume":"111","author":"CD Fahrenholtz","year":"2014","unstructured":"Fahrenholtz, C. D. et al. Preclinical efficacy of growth hormone-releasing hormone antagonists for androgen-dependent and castration-resistant human prostate cancer. Proc. Natl Acad. Sci. USA 111, 1084\u20131089 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR183","doi-asserted-by":"publisher","first-page":"15879","DOI":"10.1073\/pnas.0907843106","volume":"106","author":"CG Ziegler","year":"2009","unstructured":"Ziegler, C. G. et al. Expression of neuropeptide hormone receptors in human adrenal tumors and cell lines: antiproliferative effects of peptide analogues. Proc. Natl Acad. Sci. USA 106, 15879\u201315884 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR184","doi-asserted-by":"publisher","first-page":"112554","DOI":"10.1016\/j.biopha.2021.112554","volume":"146","author":"L Recinella","year":"2022","unstructured":"Recinella, L. et al. Antagonist of growth hormone-releasing hormone MIA-690 attenuates the progression and inhibits growth of colorectal cancer in mice. Biomed. Pharmacother. 146, 112554 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"1052_CR185","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s11523-013-0264-y","volume":"8","author":"M Jaszberenyi","year":"2013","unstructured":"Jaszberenyi, M. et al. Suppression of the proliferation of human U-87 MG glioblastoma cells by new antagonists of growth hormone-releasing hormone in vivo and in vitro. Target. Oncol. 8, 281\u2013290 (2013).","journal-title":"Target. Oncol."},{"key":"1052_CR186","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.4161\/15384101.2015.945879","volume":"13","author":"L Szalontay","year":"2014","unstructured":"Szalontay, L. et al. Novel GHRH antagonists suppress the growth of human malignant melanoma by restoring nuclear p27 function. Cell Cycle 13, 2790\u20132797 (2014).","journal-title":"Cell Cycle"},{"key":"1052_CR187","doi-asserted-by":"publisher","first-page":"11248","DOI":"10.3390\/ijms231911248","volume":"23","author":"I Gesmundo","year":"2022","unstructured":"Gesmundo, I. et al. Antagonist of growth hormone-releasing hormone potentiates the antitumor effect of pemetrexed and cisplatin in pleural mesothelioma. Int. J. Mol. Sci. 23, 11248 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"1052_CR188","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/bjh.15207","volume":"181","author":"JJ Jimenez","year":"2018","unstructured":"Jimenez, J. J. et al. A new approach to the treatment of acute myeloid leukaemia targeting the receptor for growth hormone-releasing hormone. Br. J. Haematol. 181, 476\u2013485 (2018).","journal-title":"Br. J. Haematol."},{"key":"1052_CR189","doi-asserted-by":"publisher","first-page":"10628","DOI":"10.1073\/pnas.0504102102","volume":"102","author":"G Keller","year":"2005","unstructured":"Keller, G. et al. Effective treatment of experimental human non-Hodgkin\u2019s lymphomas with antagonists of growth hormone-releasing hormone. Proc. Natl Acad. Sci. USA 102, 10628\u201310633 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR190","doi-asserted-by":"publisher","first-page":"11876","DOI":"10.1073\/pnas.1817342115","volume":"115","author":"H Kiaris","year":"2018","unstructured":"Kiaris, H. & Chatzistamou, I. Inhibition of tumor growth by agonists of growth hormone-releasing hormone. Proc. Natl Acad. Sci. USA 115, 11876\u201311878 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR191","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1002\/pros.23360","volume":"77","author":"AV Schally","year":"2017","unstructured":"Schally, A. V., Block, N. L. & Rick, F. G. Discovery of LHRH and development of LHRH analogs for prostate cancer treatment. Prostate 77, 1036\u20131054 (2017).","journal-title":"Prostate"},{"key":"1052_CR192","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00408-019-00257-w","volume":"197","author":"C Zhang","year":"2019","unstructured":"Zhang, C. et al. Growth hormone-releasing hormone receptor antagonist modulates lung inflammation and fibrosis due to bleomycin. Lung 197, 541\u2013549 (2019).","journal-title":"Lung"},{"key":"1052_CR193","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1080\/01902148.2023.2246074","volume":"49","author":"T Cui","year":"2023","unstructured":"Cui, T. et al. Alveolar epithelial cell growth hormone releasing hormone receptor in alveolar epithelial inflammation. Exp. Lung Res. 49, 152\u2013164 (2023).","journal-title":"Exp. Lung Res."},{"key":"1052_CR194","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1310","volume":"10","author":"C Zhang","year":"2021","unstructured":"Zhang, C. et al. Activity of the growth hormone-releasing hormone antagonist MIA602 and its underlying mechanisms of action in sarcoidosis-like granuloma. Clin. Transl. Immunol. 10, e1310 (2021).","journal-title":"Clin. Transl. Immunol."},{"key":"1052_CR195","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.tem.2021.03.001","volume":"32","author":"N Barabutis","year":"2021","unstructured":"Barabutis, N. Growth hormone releasing hormone in endothelial barrier function. Trends Endocrinol. Metab. 32, 338\u2013340 (2021).","journal-title":"Trends Endocrinol. Metab."},{"key":"1052_CR196","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s12079-020-00593-0","volume":"15","author":"MS Akhter","year":"2021","unstructured":"Akhter, M. S., Uddin, M. A., Schally, A. V., Kubra, K. T. & Barabutis, N. Involvement of the unfolded protein response in the protective effects of growth hormone releasing hormone antagonists in the lungs. J. Cell Commun. Signal. 15, 125\u2013129 (2021).","journal-title":"J. Cell Commun. Signal."},{"key":"1052_CR197","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2308342120","volume":"120","author":"JM Condor Capcha","year":"2023","unstructured":"Condor Capcha, J. M. et al. Growth hormone-releasing hormone receptor antagonist MIA-602 attenuates cardiopulmonary injury induced by BSL-2 rVSV-SARS-CoV-2 in hACE2 mice. Proc. Natl Acad. Sci. USA 120, e2308342120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR198","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.1073\/pnas.1018086108","volume":"108","author":"FG Rick","year":"2011","unstructured":"Rick, F. G. et al. Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia. Proc. Natl Acad. Sci. USA 108, 3755\u20133760 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1052_CR199","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1073\/pnas.1620884114","volume":"114","author":"P Popovics","year":"2017","unstructured":"Popovics, P., Schally, A. V., Salgueiro, L., Kovacs, K. & Rick, F. G. Antagonists of growth hormone-releasing hormone inhibit proliferation induced by inflammation in prostatic epithelial cells. Proc. Natl Acad. Sci. USA 114, 1359\u20131364 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"}],"updated-by":[{"DOI":"10.1038\/s41574-024-01069-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000}},{"DOI":"10.1038\/s41574-024-01081-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T00:00:00Z","timestamp":1734307200000}}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41574-024-01052-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-024-01052-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-024-01052-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T20:02:47Z","timestamp":1739476967000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41574-024-01052-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,13]]},"references-count":199,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["1052"],"URL":"https:\/\/doi.org\/10.1038\/s41574-024-01052-1","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,13]]},"assertion":[{"value":"15 October 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2024","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41574-024-01081-w","URL":"https:\/\/doi.org\/10.1038\/s41574-024-01081-w","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2024","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41574-024-01069-6","URL":"https:\/\/doi.org\/10.1038\/s41574-024-01069-6","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.V.S., R.C., X.Z., W.S. and J.M.H. are co-inventors on the patents for GHRH analogues assigned to the University of Miami and Veterans Affairs Medical Center. J.M.H. reports having a patent for cardiac cell-based therapy and holds equity in Vestion Inc. and maintains a professional relationship with Vestion Inc. as a consultant and member of the Board of Directors and Scientific Advisory Board. Vestion Inc. did not play a role in the preparation or funding of the article. J.M.H. is the Chief Scientific Officer, a compensated consultant and board member for Longeveron Inc. and holds equity in Longeveron. J.M.H. is also the co-inventor of intellectual property licensed to Longeveron. Longeveron did not play a role in the preparation or funding of this article. The University of Miami is an equity owner in Longeveron Inc., which has licensed intellectual property from the University of Miami. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}